Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis

• Published in: Frontiers in immunology Vol. 12; p. 696766
• Main Authors: Wang, Xu, Yuan, Xiao, Su, Yuting, Hu, Jing, Ji, Qian, Fu, Shengqiao, Li, Rongkun, Hu, Lipeng, Dai, Chunhua
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 20-07-2021
• Subjects: Animals; Antibodies, Neutralizing - pharmacology; Bacteria - metabolism; Benzenesulfonates - pharmacology; Colitis - immunology; Colitis - metabolism; Colitis - microbiology; Colitis - prevention & control; Colon - drug effects; Colon - immunology; Colon - metabolism; Colon - microbiology; Disease Models, Animal; Drug Therapy, Combination; Dysbiosis; Gastrointestinal Microbiome; Immunology; inflammation; inflammatory bowel disease (IBD); Mice; Mice, Inbred C57BL; Mice, Knockout; P2RX1; Purinergic P2X Receptor Antagonists - pharmacology; purinergic receptor; purinergic signaling; Receptors, Purinergic P2X1 - genetics; Receptors, Purinergic P2X1 - metabolism; Signal Transduction; Tumor Necrosis Factor Inhibitors - pharmacology; purinergic receptor; purinergic signaling; inflammatory bowel disease (IBD); inflammation; P2RX1
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2021.696766

Inflammatory bowel disease (IBD) remains one of the most prevalent gastrointestinal diseases worldwide. Purinergic signaling has emerged as a promising therapeutic target of inflammation-associated diseases. However, little is known about the specific roles of purinergic receptors in IBD. In the present study, expression profile of purinergic receptors was screened in the public Gene Expression Omnibus (GEO) datasets, and we found that expression of P2RX1 was significantly upregulated in inflamed colon tissues. Then, purinergic receptor P2RX1 was genetically ablated in the background of C57BL/6 mice, and dextran sulfate sodium (DSS) was used to induce mice colitis. RNA sequencing results of colon tissues showed that genetic knockout of P2RX1 suppressed the inflammation responses in DSS-induced mice colitis. Flow cytometry indicated that neutrophil infiltration was inhibited in P2RX1 ablated mice. 16S ribosomal DNA sequencing revealed major differences of intestinal microbiota between WT and P2RX1 ablated mice. Functional metagenomics prediction indicated that the indole alkaloid biogenesis pathway was upregulated in
gene ablated mice. Further studies revealed that microbiota metabolites (indole alkaloid)-involved aryl hydrocarbon receptor (AhR)/IL-22 axis was associated with the beneficial effects of P2RX1 ablation. Finally, we found that a specific P2RX1 inhibitor succeeded to improve the therapeutic efficiency of anti-TNF-α therapy in DSS-induced mice colitis. Therefore, our study suggests that targeting purinergic receptor P2RX1 may provide novel therapeutic strategy for IBD.